Celcuity (CELC) Share-based Compensation Growth (1y) (2017 - 2025)
Celcuity (CELC) Share-based Compensation Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
308.47% |
| Date | Value |
|---|
| Dec 31, 2025 |
308.47% |
| Sep 30, 2025 |
251.06% |
| Jun 30, 2025 |
91.64% |
| Mar 31, 2025 |
83.62% |
| Dec 31, 2024 |
86.31% |
| Sep 30, 2024 |
74.18% |
| Jun 30, 2024 |
10.49% |
| Mar 31, 2024 |
4.53% |
| Dec 31, 2023 |
9.05% |
| Sep 30, 2023 |
-9.36% |
| Jun 30, 2023 |
-15.96% |
| Mar 31, 2023 |
68.36% |
| Dec 31, 2022 |
23.77% |
| Sep 30, 2022 |
74.74% |
| Jun 30, 2022 |
181.22% |
| Mar 31, 2022 |
68.40% |
| Dec 31, 2021 |
115.55% |
| Sep 30, 2021 |
55.90% |
| Jun 30, 2021 |
27.68% |
| Mar 31, 2021 |
-3.35% |
